Om

Nuvation Bio Inc. Class A Common Stock represents ownership in Nuvation Bio, a global oncology company focused on developing differentiated therapeutic candidates for difficult-to-treat cancers. The company’s current work centers on advancing a portfolio of oncology programs that includes targeted therapies, brain-penetrant inhibitors, and drug-drug conjugate candidates designed to address unmet needs across several cancer types. Its pipeline spans areas such as non-small cell lung cancer, gliomas, and other solid tumors, reflecting a research and development model built around precision medicine and novel mechanisms of action. Nuvation Bio operates as a biopharmaceutical business within the healthcare sector, where it contributes to the broader oncology market through clinical-stage drug development and scientific innovation.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NUVATION BIO MED ENDAVU: Køb Nuvation Bio ($1E30) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Nuvation Bio, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.